The Drug Enforcement Administration yesterday published a final rule implementing a 2016 law allowing nurse practitioners and physician assistants who meet certain requirements to prescribe and dispense drugs for the treatment of opioid use disorder, including for maintenance, detoxification, overdose reversal and relapse prevention. Previously only physicians could qualify to provide this medication-assisted treatment. The Comprehensive Addiction and Recovery Act of 2016 expanded the category of eligible providers to include nurse practitioners and physician assistants until October 2021 to increase access for people in underserved areas. To qualify, nurse practitioners and physician assistants must be licensed under state law to prescribe certain controlled substances and complete at least 24 hours of initial training. If state law requires, they also must be supervised by or work in collaboration with a qualified physician.

Related News Articles

Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…